The synthesis of the molecular chaperone 2,5-dideoxy-2,5-imino-d

Add time:08/09/2019    Source:sciencedirect.com

The iminosugar 2,5-dideoxy-2,5-imino-d-altritol (DIA, 2) is a powerful competitive inhibitor of α-galactosidase A and has shown much promise as a pharmacological chaperone for the treatment for Fabry disease. Notwithstanding, syntheses of DIA are in want of optimisation. Accordingly, we report on the total synthesis of DIA in 7 steps and in 22% overall yield from readily available d-tagatose. This is the shortest and most efficient synthesis of DIA to date, with key steps in our synthetic strategy including a diastereoselective reductive amination and an I2-mediated carbamate annulation.

We also recommend Trading Suppliers and Manufacturers of Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4β-propyl-2α-pyrrolidinyl]carbonyl]amino]-1-thio-α-D-glycero-D-galacto-octopyranoside-7-ulose (cas 17057-59-9). Pls Click Website Link as below: cas 17057-59-9 suppliers

Prev:Thermal, oxidative and radiation stability of polyimides. Part IV: Polyimides based on N-[4-benzoyl-2-(2,5-dioxo-2,5-dihydro-pyrrol-1-yl)-phenyl]-acetamide and different diamines
Next:The anti-inflammatory effects of N-methyl-(2S,4R)-trans-4-hydroxy-l)